Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Stellantis N.V. Major Shareholding Notification 2021

Jan 25, 2021

6222_mrq_2021-01-25_5153f24d-ab39-4426-9bfb-9ec78036d076.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SC 13D 1 bpi13da.htm SCHEDULE 13D Licensed to: asdf Document created using EDGARfilings PROfile 7.2.0.0 Copyright 1995 - 2021 Broadridge PROfilePageNumberReset%Num%1%%%

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934 (Amendment No.)*

Stellantis N.V.

(Name of Issuer)

Common Shares, nominal value €0.01 per share

(Title of Class of Securities)

N82405106

(CUSIP Number)

Sophie Paquin

Bpifrance Participations S.A.

27-31 avenue du Général Leclerc

94710 Maisons-Alfort Cedex

France

+33 1 53 89 55 73

With a copy to:

Daniel Hurstel

Gabriel Flandin

Willkie Farr & Gallagher LLP

21-23 rue de la Ville l'Evêque

75008 Paris

+33 1 53 43 45 00

((Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

January 16, 2021

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

  • The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“ Act ”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

PROfilePageNumberReset%Num%1%%%

CUSIP No. N82405106 — 1. Name of Reporting Person Lion Participations S.A.S.
2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3. SEC Use Only
4. Source of Funds WC
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6. Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0
8. Shared Voting Power 192,703,907
9. Sole Dispositive Power 0
10. Shared Dispositive Power 192,703,907
11. Aggregate Amount Beneficially Owned by Each Reporting Person 192,703,907
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13. Percent of Class Represented by Amount in Row (11) 6.2%*
14. Type of Reporting Person (See Instructions) OO
  • Percentage calculated based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info.

1

CUSIP No. N82405106 — 1. Name of Reporting Person Bpifrance Participations S.A.
2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3. SEC Use Only
4. Source of Funds WC
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6. Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0
8. Shared Voting Power 192,703,907
9. Sole Dispositive Power 0
10. Shared Dispositive Power 192,703,907
11. Aggregate Amount Beneficially Owned by Each Reporting Person 192,703,907
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13. Percent of Class Represented by Amount in Row (11) 6.2%*
14. Type of Reporting Person (See Instructions) OO
  • Percentage calculated based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info.

2

CUSIP No. N82405106 — 1. Name of Reporting Person Bpifrance S.A.
2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3. SEC Use Only
4. Source of Funds WC
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6. Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0
8. Shared Voting Power 192,703,907
9. Sole Dispositive Power 0
10. Shared Dispositive Power 192,703,907
11. Aggregate Amount Beneficially Owned by Each Reporting Person 192,703,907
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13. Percent of Class Represented by Amount in Row (11) 6.2%*
14. Type of Reporting Person (See Instructions) OO
  • Percentage calculated based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info.

3

CUSIP No. N82405106 — 1. Name of Reporting Person Caisse des Dépôts et Consignations
2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3. SEC Use Only
4. Source of Funds WC
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6. Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 6,558
8. Shared Voting Power 202,036,101
9. Sole Dispositive Power 6,558
10. Shared Dispositive Power 202,036,101
11. Aggregate Amount Beneficially Owned by Each Reporting Person 202,042,659
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13. Percent of Class Represented by Amount in Row (11) 6.5%*
14. Type of Reporting Person (See Instructions) OO
  • Percentage calculated based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info.

4

CUSIP No. N82405106 — 1. Name of Reporting Person EPIC Bpifrance
2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3. SEC Use Only
4. Source of Funds WC
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6. Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0
8. Shared Voting Power 192,703,907
9. Sole Dispositive Power 0
10. Shared Dispositive Power 192,703,907
11. Aggregate Amount Beneficially Owned by Each Reporting Person 192,703,907
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13. Percent of Class Represented by Amount in Row (11) 6.2%*
14. Type of Reporting Person (See Instructions) OO
  • Percentage calculated based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info.

5

Item 1. Security and Issuer.

This Schedule 13D (this “ Schedule 13D ”) relates to the Ordinary Shares, nominal value €0.01 per share (the “ Common Shares ”) of Stellantis N.V. (the “ Issuer ”). The Issuer’s principal executive offices are located at Singaporestraat 92-100, 1175 RA Lijnden, the Netherlands.

Item 2. Identity and Background.

(a) This Schedule 13D is filed jointly by

(i) Lion Participations S.A.S., a société par actions simplifiée incorporated under the laws of the Republic of France (“ Lion Participations ”),

(ii) Bpifrance Participations S.A., a société anonyme incorporated under the laws of the Republic of France (“ Bpifrance Participations ”),

(iii) Bpifrance S.A. (“ Bpifrance ”), a société anonyme incorporated under the laws of the Republic of France,

(iv) Caisse des Dépôts et Consignations, a French special public entity ( établissement spécial ) (“ CDC ”), and

(v) EPIC Bpifrance, a French public institution of industrial and commercial nature (“ EPIC ”).

Lion Participations, Bpifrance Participations, Bpifrance, CDC and EPIC are referred to in this Schedule 13D individually as a “ Reporting Person ” and collectively as the “ Reporting Persons .” This Schedule 13D is being filed pursuant to a Joint Filing Agreement (the “ Joint Filing Agreement ”), attached hereto as Exhibit 1.

(b) The principal address for Lion Participations is 6-8 boulevard Haussmann 75009 Paris, France. The principal address for Bpifrance Participations, Bpifrance and EPIC is 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. The principal address for CDC is 56, rue de Lille, 75007 Paris, France.

(c) Lions Participations is principally a French holding company without its own independent operations and a wholly-owned subsidiary of Bpifrance Participations. Bpifrance Participations is a French public company principally engaged in the business of equity financing via direct investments or fund of funds and a wholly-owned subsidiary of Bpifrance. Bpifrance is a French financial institution principally engaged in the provision of financing to businesses. CDC and EPIC each hold 49.3% of the share capital of Bpifrance and jointly control Bpifrance. CDC is principally engaged in the business of long-term investments. EPIC is a French public institution of industrial and commercial nature principally engaged in the holding of Bpifrance’s shares.

Attached as Appendices A, B, C, D and E is information concerning the executive officers and directors of Lion Participations, Bpifrance Participations, Bpifrance, CDC and EPIC, respectively, which is incorporated by reference into this Item 2.

(d)-(e) None of the Reporting Persons, nor, to the best of their knowledge, any of the persons named in Appendices A, B, C, D and E attached hereto has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

6

Item 3. Source and Amount of Funds or Other Consideration.

On January 16, 2021, pursuant to that certain Combination Agreement, dated as of December 17, 2019, by and between Fiat Chrysler Automobiles N.V. (“ FCA ”) and Peugeot S.A. (“ PSA ”) (as amended September 14, 2020, the “ Combination Agreement ”), PSA merged with and into FCA (the “ Merger ”) with FCA surviving the Merger as the Issuer and renamed “Stellantis N.V.”

Upon consummation of the Merger, each share of PSA ordinary stock (“ PSA Shares ”) outstanding immediately prior to the Merger converted into the right to receive 1.742 Common Shares.

In accordance with the terms of the Combination Agreement, upon consummation of the Merger, the 110,622,220 PSA Shares held by Lion Participations converted into 192,703,907 Common Shares (the “ Direct Lion Shares ”), and (ii) the 5,357,175 PSA shares held by CDC, as a result of its ownership stake in CNP Assurances S.A. and La Banque Postale S.A., converted into 9,332,194 Common Shares (the “ Indirect CDC Shares ”).

The foregoing description of the Combination Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such document, which is filed as Exhibit 2 hereto and incorporated by reference into this Item 3.

Item 4. Purpose of Transaction.

Lion Participations acquired the Direct Lion Shares as part of the Merger described above. CDC acquired the Indirect CDC Shares as part of the Merger described above. Item 3 is incorporated by reference into this Item 4. Additionally, CDC previously acquired 6,558 Common Shares (the “ Direct CDC Shares ”) for investment purposes.

Except as set forth in this Schedule 13D, none of the Reporting Persons currently has any plans or proposals that relate to or would result in any of the matters described in Item 4(a)-(j) of Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.

Item 5. Interest in Securities of the Issuer.

The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Schedule 13D and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.

The percentages set forth in this Item 5 are based on 3,119,934,695 Common Shares outstanding as of January 22, 2021 at 4PM EST, as reported by the Issuer at https://www.stellantis.com/en/investors/stock-and-shareholder-info/stock-info

(a) and (b) As a result of the Merger, each Reporting Person other than CDC beneficially owns, and may be deemed to have shared voting and dispositive power with respect to, 192,703,907 Common Shares, which represents 6.2% of the issued and outstanding Common Shares. As a result of the Merger, CDC beneficially owns, and may be deemed to have shared voting and dispositive power with respect to, 202,042,659 Common Shares, which represents 6.5% of the issued and outstanding Common Shares. The Reporting Persons other than CDC disclaim beneficial ownership of the Indirect CDC Shares and the Direct CDC Shares.

(c) There have been no reportable transactions with respect to the Common Shares of the Issuer within the last 60 days by the Reporting Persons other than as described in this Schedule 13D.

(d) Not applicable.

(e) Not applicable.

7

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Pursuant to the Articles of Association of the Issuer (the “ AOA ”), so long as Bpifrance and any affiliate of Bpifrance that is controlled by Bpifrance (collectively, “ BPI ”), jointly hold 5% or more of the issued and outstanding Common Shares, and Bpifrance has not undergone a Change of Control (as defined in the AOA), the board of directors of the Issuer (the “ Board ”) will include a director nominated by Bpifrance. Notwithstanding the foregoing, if at any time within the 6 years following the closing of the Merger, (a) Common Shares held by BPI represent between 4% and 5% of the issued and outstanding Common Shares; (b) Établissements Peugeot Frère, FFP S.A. and their affiliates (collectively, “ EPF/FFP ”), have not lost their right to nominate a director to the Board pursuant to the AOA; and (c) the number of Common Shares held by BPI and EPF/FFP represents, in aggregate, 8% or more of the issued and outstanding Common Shares, BPI will maintain its right to nominate a director to the Board. In connection with the Merger, Bpifrance nominated, and the shareholders of the Issuer elected, Nicolas Dufourcq to the Board. The AOA further provides that a shareholder of the Company will be eligible to receive a special voting share of the Issuer, which entitles the shareholder to exercise 1 additional vote in a vote of the Common Shares, for each Common Share held without interruption for a 3-year period and registered in the “Loyalty Register” of the Company. The Reporting Persons have registered the Direct Lion Shares in the Loyalty Register. The foregoing description of the AOA does not purport to be complete and is qualified in its entirety by reference to the full text of such document, which is filed as Exhibit 3 hereto and incorporated by reference into this Item 6.

In connection with the Merger, Lion Participations and Bpifrance Participations entered into a letter agreement, dated December 17, 2019 (the “ Letter Agreement ”) with PSA, setting forth, among other things, the following undertakings relating to the Merger and the future governance of the Issuer: support of the Merger; a 7-year prohibition against the acquisition of, and solicitation of proxies for, Common Shares; and a 3-year transfer restriction, subject to an exception permitting the transfer of PSA Shares (prior to the Merger) or Common Shares (following the Merger) amounting to no more than 2.5% of the Common Shares to persons unaffiliated with Lion Participations and Bpifrance Participations. The foregoing description of the Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such document, which is filed as Exhibit 4 hereto and incorporated by reference into this Item 6.

On January 25, 2021, the Reporting Persons entered into the Joint Filing Agreement, in which the Reporting Persons agreed to the joint filing of statements on Schedule 13D with respect to the securities of the Issuer. The foregoing description of the Joint Filing Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such document, which is filed as Exhibit 1 hereto and incorporated by reference into this Item 6.

Item 7. Material to be Filed as Exhibits.

1 – Joint Filing Agreement.

2 – Combination Agreement (Incorporated by reference to Exhibit 2.1 of the Registration Statement on Form F-4 filed by FCA with the U.S. Securities and Exchange Commission on November 20, 2020 (the “ Registration Statement ”)).

3 – AOA (Incorporated by reference to Exhibit 3.3 of the Registration Statement).

4 – Letter Agreement (Incorporated by reference to Exhibit 10.4 of the Registration Statement).

8

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 25, 2021
Lion Participations S.A.S.
By: Bpifrance Participations S.A.
By: /s/ Nicolas Dufourcq
Name: Nicolas Dufourcq
Title: Chief Executive Officer of Bpifrance Participations
Bpifrance Participations S.A.
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs
Bpifrance S.A.
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs
Caisse des Dépôts
By: /s/ Laurence Giraudon
Name: Laurence Giraudon
Title: Chief Operating Officer Finance and Operations Department Asset Management Division
EPIC Bpifrance
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs

9

APPENDIX A

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

LION PARTICIPATIONS S.A.S.

The name, business address and present principal occupation or employment of each of the directors and executive officers of Lion Participations S.A.S. are set forth below. The business address of each director and executive officer is Lion Participations S.A., 6-8 boulevard Haussmann 75009 Paris, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

DIRECTOR

Name Present Principal Occupation or Employment
BPIFRANCE PARTICIPATIONS S.A Chairman, sole shareholder

10

APPENDIX B

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

BPIFRANCE PARTICIPATIONS S.A.

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Participations S.A. are set forth below. The business address of each director and executive officer is Bpifrance Participations S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

BOARD OF DIRECTORS

Name Present Principal Occupation or Employment
NICOLAS DUFOURCQ Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance
VIRGINIE FERNANDES Director , Head of the Steering Department at Caisse des Dépôts
ANTOINE SAINTOYANT Director , Director of strategic holdings at Caisse des Dépôts
FREDERIC SAINT-GEOURS Director , Director of Société nationale SNCF
FRENCH STATE, represented by CHARLES SARRAZIN Director , in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de l’Etat (French State Shareholding Agency)
CONSTANCE VALIGNY Director , Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury)
CHLOE MAYENOBE Director , deputy CEO Natixis Payment
VICTOIRE AUBRY Director , Chief Financial Officer of Icade
SOPHIE STABILE Director, Founder and CEO of Révérence
ROMAIN BONENFANT Director, Chief , Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance

EXECUTIVE OFFICERS

Name Present Principal Occupation or Employment
NICOLAS DUFOURCQ Chief Executive Officer
JOSÉ GONZALO Executive Director
PIERRE BENEDETTI Chief Financial Officer

11

APPENDIX C

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

BPIFRANCE S.A.

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance S.A. are set forth below. The business address of each director and executive officer is Bpifrance S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

DIRECTORS

Name Present Principal Occupation or Employment
ERIC LOMBARD Chairman, Chief Executive Officer of the Caisse des Dépôts
NICOLAS DUFOURCQ Director, Chief Executive Officer of Bpifrance and Director, Chairman and Chief Executive Officer of Bpifrance Participations
MARTIN VIAL Director , Chairman of the Agence des Participations de l’Etat (French State Shareholding Agency)
MARIE DELEAGE Director representing the employees of Bpifrance
PHILIPPE BAYEUX Director representing the employees of Bpifrance
VIRGINIE CHAPRON-DU JEU Director , Group Finance Director of the Caisse des Dépôts
CLAIRE DUMAS Director , Finance Director at Société Générale
CATHERINE LAGNEAU Director , Deputy Director of the General council of economy
ANTOINE SAINTOYANT Director, Director of strategic holdings at Caisse des Dépôts
BERNARD DELPIT Director , Chief Financial Officer of Safran
ANNABEL ANDRE Director, Vice-president of the Regional Council of Auvergne-Rhone-Alpes, delegate for the economy and companies
HAROLD HUWART Director, Vice-president of the Regional Council of Centre-Val-de-Loire, in charge of the economy, farming and associations
CAROLE ABBEY DUVAL Director , in charge of strategic holdings at Caisse des Dépôts
BARBARA LAVERNOS DUPUIS Director , Chief Technology and Operations Officer at L’Oréal
DIANE SIMIU Director, deputy of the general commissioner for sustainable development at the Ministry for economic and solidarity transition

12

APPENDIX D

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

CAISSE DES DÉPÔTS

The name, business address and present principal occupation or employment of each of the members of the Management Committee of Caisse des Dépôts are set forth below. The business address of each director and executive officer is Caisse des Dépôts, c/o 56, rue de Lille, 75007 Paris, France. Unless otherwise indicated, each such person is a citizen of France.

MANAGEMENT COMMITTEE

Name Present Principal Occupation or Employment
ERIC LOMBARD Chief Executive Officer of Caisse des Dépôts
OLIVIER SICHEL Deputy Chief Executive Officer of Caisse des Dépôts
NICOLAS DUFOURCQ Chief Executive Officer of Bpifrance
VIRGINIE CHAPRON-DU-JEU Director of Finance for the Caisse des Dépôts Group
PIERRE CHEVALIER Head of Legal and Tax Department
NATHALIE TUBIANA Risk Director of the Caisse des Dépôts Group
OLIVIER MAREUSE Chief Investment officer - Director of Savings Funds at Caisse des Dépôts
CATHERINE MAYENOBE Secretary General of Caisse des Dépôts Group
PAUL PENY Caisse des Dépôts Group Human Resources Director
SOPHIE QUATREHOMME Group Corporate Communications Director
MICHEL YAHIEL Pensions and Solidarity Director
ANTOINE SAINTOYANT Director of strategic holdings at Caisse des Dépôts

13

APPENDIX E

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

EPIC BPIFRANCE

The name, business address and present principal occupation or employment of each of the directors and executive officers of EPIC Bpifrance are set forth below. The business address of each director and executive officer is EPIC Bpifrance, 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

DIRECTORS

Name Present Principal Occupation or Employment
CHRISTIAN BODIN Chairman, Chief Executive Officer of EPIC Bpifrance
PIERRE-LOUIS AUTIN Director , Head of department SITTAR at the Higher Education, Research and Innovation Ministry
YANN POUËZAT Director , Deputy Director at the Directorate of Financing, Industry and Market of the Ministry of Economy and Finance
ALBAN HAUTIER Director , Deputy Director at the General Directorate for Budget of the Ministry of Economy and Finance
VINCENT TEJEDOR Director, Assistant Director in charge of the development of enterprises, General Directorate for Companies of the Ministry of Economy and Finance
MARIE-ANNE LAVERGNE Director , Investment Manager at the Agence des Participations de l’Etat (French State Shareholding Agency)
NAOMI PERES Director , Deputy General Secretary for Public Investment

14